Evogene Ltd Ordinary Shares (EVGN)

About EVGN

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a com…

Sector

Industrials

Industry

Agricultural Chemicals

Employees

52

Website

www.evogene.com

Fundamentals

1-day range

$0.5909$0.665

Market cap

$7.11M

P/E (trailing)

—

P/E (forward)

-0.75

EPS (trailing)

$-2.04

Dividend yield

—

Beta

0.68

Avg. volume

1.88M

Forecasts

1 analyst ratings

Evogene Ltd Ordinary Shares Competitors

Chosen by industry and closest market cap.

• EVGN

  Evogene Ltd Ordinary Shares

  $0.55

  ▲ 1.85%
  Market cap $7.11MP/E —
  $0.37$1.5
• NXTS

  Nexentis Technologies Inc. Common Stock

  $1.77

  ▼ 7.33%
  Market cap $3.01MP/E —
  $1.43$58.8
• UAN

  CVR Partners LP Common Units representing Limited Partner Interests

  $125.28

  ▼ 0.79%
  Market cap $1.33BP/E 8.33
  $84.13$139.5
• SMG

  Scotts Miracle-Gro Company (The) Common Stock

  $60.56

  ▼ 0.05%
  Market cap $3.97BP/E 49.61
  $52$75.34
• MOS

  Mosaic Company (The) Common Stock

  $23.61

  ▼ 0.63%
  Market cap $6.93BP/E —
  $19.8$36.99
• CF

  CF Industries Holdings Inc. Common Stock

  $125.76

  ▲ 0.04%
  Market cap $18.17BP/E 8.64
  $75.42$141.96

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/18/2026
• CORRECTION: Evogene Q2 EPS $(0.13) Beats $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate
  Benzinga · 8/18/2026
• 12 Health Care Stocks Moving In Monday's Pre-Market Session
  Benzinga · 8/10/2026

• Leon Recanati · August 11, 2026 · Buy

  460.0K @ $0.635
• Leon Recanati · August 4, 2026 · Buy

  800.0K @ $0.5